News

BOP preliminary trial results presented at EANM 2023 conference

View more

Sep 22, 2023

Emerging PSMA PET Agent May Offer Improved Detection of Prostate Cancer

View more

Sep 22, 2023

Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium

View more

Sep 22, 2023

Blue Earth Therapeutics Announces Promising Results of Preclinical Evaluation of 225Ac-rhPSMA-10.1 for Potential Targeted Alpha Therapy of Prostate Cancer

View more

Sep 22, 2023

Orano Med and Orbit Discovery Enter Collaboration to Discover Novel Targeted Radioligand Therapies for Cancer

View more

Sep 22, 2023

PET/CT-based model predicts prostate cancer in the 'PSA grey zone'

View more

Sep 14, 2023